Jason Vincent Selected Research

Class 2 Receptor-Like Protein Tyrosine Phosphatases

2/2021	Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents.
1/2021	Detection of Tumor-Specific PTPmu in Gynecological Cancer and Patient Derived Xenografts.
1/2020	PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma.
5/2019	A PTPmu Biomarker is Associated with Increased Survival in Gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason Vincent Research Topics

Disease

6	Neoplasms (Cancer) 11/2021 - 01/2015
4	Glioma (Gliomas) 01/2020 - 01/2015
2	Brain Neoplasms (Brain Tumor) 05/2019 - 01/2015
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2020

Drug/Important Bio-Agent (IBA)

4	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 02/2021 - 05/2019
3	Contrast MediaIBA 02/2021 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 02/2021 - 05/2019
2	Peptides (Polypeptides)IBA 01/2021 - 01/2020
2	Cell Adhesion MoleculesIBA 01/2021 - 05/2019
1	HydrogelsIBA 11/2021
1	Pharmaceutical PreparationsIBA 11/2021
1	Texas redIBA 01/2021
1	LipidsIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	IronIBA 01/2020
1	AzidesIBA 12/2019
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 12/2019
1	gadobenic acid (gadobenate dimeglumine)FDA Link 12/2019
1	Indicators and Reagents (Reagents)IBA 05/2019
1	Complement System Proteins (Complement)IBA 05/2019
1	gadoversetamide (OptiMARK)FDA Link 01/2015
1	GadoliniumIBA 01/2015

Therapy/Procedure

1	Precision Medicine 11/2021
1	Microbubbles 02/2021